Curavit Clinical Research, an innovative clinical research organization (CRO) and Remote Clinical Site, announces the acquisition of the CRO assets of Lindus Health. This strategic move significantly expands Curavit’s global footprint into Europe, providing life science sponsors with unified, end-to-end solutions for decentralized, hybrid, and traditional clinical trials across both North America and Europe. With full-service CRO capabilities paired with dedicated Remote Clinical Site operations, Curavit is optimized to execute decentralized, hybrid, and traditional clinical studies that lower trial costs, improve participant retention, and deliver clinical grade data across the U.S. and Europe.
Read the full article: Curavit Expands Clinical Research Capabilities with Acquisition of Lindus Health CRO Assets, Accelerating Global Trial Execution for Life Science Sponsors //
Source: https://www.prnewswire.com/news-releases/curavit-expands-clinical-research-capabilities-with-acquisition-of-lindus-health-cro-assets-accelerating-global-trial-execution-for-life-science-sponsors-302854586.html